Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2004Cerebrovascular Diseases

Prevention

View Full Paper
Ask AI
Bookmark
Share

Key result

No abstract available; the text only provides citation metadata for a guidelines article on prevention.

Authors

DLDidier LeysUniversity of BernHKHubert KwiecińskiGoethe University FrankfurtJBJulien BogousslavskyUniversity of Geneva

Discussion

Loading...

Member takes

Implication

No abstract for cerebrovascular prevention guidelines; leaves open evidence synthesis for clinicians and researchers.

Key Points

  • Provide evidence-based clinical recommendations for the prevention of stroke and related cerebrovascular events.
  • Synthesized expert consensus and contemporary clinical trial evidence addressing primary and secondary cerebrovascular prevention.
  • Assessed interventions including risk factor control, pharmacological therapies, and surgical options across cardiovascular and neurological domains.
  • Identified blood pressure management, antithrombotic therapies, and lipid-lowering agents as essential components of risk reduction.
  • Established structured clinical recommendations prioritizing individualized risk stratification to prevent recurrent ischemic events.

Cite This Study

Leys et al. (2004) studied this question. No abstract available; the text only provides citation metadata for a guidelines article on prevention.

synapsesocial.com/papers/6a78558f6c53f758bc1ecc77https://doi.org/10.1159/000074817

Topics

Hypertension managementPersistent AF managementAtrial fibrillation
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effects of Atorvastatin on Stroke in Patients With Unstable Angina or Non-Q-Wave Myocardial Infarction2002 · 193 citations
  2. 2Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol2002 · 5,434 citations
  3. 3Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients2000 · 8,694 citations
  4. 4The Causes and Risk of Stroke in Patients with Asymptomatic Internal-Carotid-Artery Stenosis2000 · 883 citations
  5. 5A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke2001 · 1,180 citations